DPYD - Dihydropyrimidine dehydrogenase [NADP(+)] - human protein (Medical)
Home Recent activites arrow-down favorite My favorites arrow-down favorite My labels arrow-down Downloads
Back to ...  
Publication View

DPYD »  Dihydropyrimidine dehydrogenase [NADP(+)]   [ EC ]  (DPD)
Protein also known as:  Dihydrothymine dehydrogenase.
Gene name:  DPYD
Entry whose protein(s) existence is based on evidence at protein level
extend overview
1 140 2

Displayed isoform: Iso 1     



 show evidences
Dihydropyrimidine dehydrogenase deficiency (DPYDD) [MIM:274270]: A metabolic disorder with large phenotypic variability, ranging from no symptoms to a convulsive disorder with motor and mental retardation. It is characterized by persistent urinary excretion of excessive amounts of uracil, thymine and 5-hydroxymethyluracil. Patients suffering from this disease show a severe reaction to the anticancer drug 5-fluorouracil. The disease is caused by mutations affecting the gene represented in this entry.  
  • UniProtKB
According to Orphanet, this protein is involved in the following diseases:
1p21.3 microdeletion syndrome  293948  
5-fluorouracil toxicity  240839  
Capecitabine toxicity  240855  
Dihydropyrimidine dehydrogenase deficiency  1675  
Susceptibility to adverse reaction due to 5-fluorouracil treatment  240955  
Susceptibility to adverse reaction due to capecitabine treatment  240963  
According to DrugBank, this protein binds/interacts with the following drugs:
Capecitabine  DB01101  
Flavin adenine dinucleotide  DB03147  
Fluorouracil  DB00544  


Disease mutation  definition   [KW-0225]
Technical term 
Reference proteome  definition   [KW-1185]

Further external links

Organism-specific databases
CTD: 1806
MIM: 274270
PharmGKB: PA145
Polymorphism databases
DMDM: 160332325
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.